Use of an Oral Beta-2 Agonist in Persons With Spinal Cord Injury

NCT00755079 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

40

Enrollment

FED

Sponsor class

Conditions

Spinal Cord Injury

Interventions

DRUG: extended release beta-2 adrenergic agonist
DRUG: placebo

Sponsor

US Department of Veterans Affairs